Simulations Plus, Inc. (SLP)
NASDAQ: SLP · Real-Time Price · USD
16.11
-0.36 (-2.18%)
Oct 9, 2025, 11:25 AM EDT - Market open
Simulations Plus Revenue
Simulations Plus had revenue of $20.36M in the quarter ending May 31, 2025, with 9.81% growth. This brings the company's revenue in the last twelve months to $80.38M, up 20.01% year-over-year. In the fiscal year ending August 31, 2024, Simulations Plus had annual revenue of $70.01M with 17.52% growth.
Revenue (ttm)
$80.38M
Revenue Growth
+20.01%
P/S Ratio
4.11
Revenue / Employee
$325,437
Employees
247
Market Cap
324.27M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2024 | 70.01M | 10.44M | 17.52% |
| Aug 31, 2023 | 59.58M | 5.67M | 10.52% |
| Aug 31, 2022 | 53.91M | 7.44M | 16.01% |
| Aug 31, 2021 | 46.47M | 4.88M | 11.73% |
| Aug 31, 2020 | 41.59M | 7.62M | 22.43% |
| Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
SLP News
- 1 day ago - SLP FRAUD NOTICE: Simulations Plus, Inc. Hit with Securities Fraud Investigation Due to Impairment Charges -- Contact BFA Law if You Suffered Losses - GlobeNewsWire
- 3 days ago - SLP SHAREHOLDER NOTICE: Simulations Plus, Inc. Investigated for Securities Fraud after 26% Stock Drop – Contact BFA Law - GlobeNewsWire
- 7 days ago - Johnson Fistel Investigates Simulations Plus Following Reports of Financial and Internal Control Issues - GlobeNewsWire
- 13 days ago - Simulations Plus (SLP) Faces Investor Scrutiny After Asset Impairment and Auditor Firing-- Hagens Berman - GlobeNewsWire
- 17 days ago - SLP SECURITIES NEWS: Why did Simulations Plus, Inc. Stock Drop 26%? Investors with Losses Reminded to Contact BFA Law - GlobeNewsWire
- 17 days ago - The Bottom Fishing Club - Simulations Plus: Huge Potential In AI Drug Discovery - Seeking Alpha
- 27 days ago - SLP SECURITIES NOTICE: Did Simulations Plus, Inc. Mislead Investors? Contact BFA Law if You Lost Money on Your Investment - GlobeNewsWire
- 27 days ago - Simulations Plus, Inc. (SLP) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha